An Analytical Method to Monitor Dietary Fat Intake
|
By LabMedica International staff writers Posted on 25 May 2020 |

Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)
An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







